Factors affecting levodopa effects in Parkinson's disease

被引:0
|
作者
Ogawa, N [1 ]
机构
[1] Okayama Univ, Sch Med, Inst Mol & Cellular Med, Dept Neurosci, Okayama 7008558, Japan
关键词
dopamine agonist; monoamine oxidase-B (MAO-B) inhibitor; catechol-O-methyltransferase (COMT) inhibitor; blood-brain barrier; age at onset; large neutral amino acids; gastric acidity;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Levodopa is the gold standard for the treatment of Parkinson's disease (PD) because of its outstanding clinical efficacy. However, the majority of patients experience various adverse reactions, including the wearing-off phenomenon, the on-off phenomenon, dyskinesia and psychiatric symptoms. The response to levodopa depends not only on the intrinsic responsiveness of the patients, but also on various other important factors including the type of levodopa preparation, its absorption/metabolism, the blood-brain barrier, age at onset of disease and concomitant use of anti-parkinsonian drugs. This review summarizes factors which influence the effects of levodopa in PD, To minimize levodopa-induced adverse reactions and to relieve long-term parkinsonian symptoms,levodopa therapy should be conducted by taking these factors into consideration.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [11] Effects of levodopa on finger and orofacial movements in Parkinson's disease
    Gentil, M
    Tournier, CL
    Perrin, S
    Pollak, P
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1998, 22 (08): : 1261 - 1274
  • [12] The effects of Nardosinone on levodopa intervention in the treatment of Parkinson's disease
    Liu, Mengmeng
    Xue, Jingwen
    Cao, Yuxin
    Hao, Zhuangzhuang
    Wang, Yuqing
    Li, Jiayuan
    Jiang, Tingyue
    Shi, Jinli
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [13] Effects of intraduodenal levodopa infusion therapy on Parkinson's disease
    Tomantschger, V.
    Tautscher-Basnett, G.
    Freimueller, M.
    MOVEMENT DISORDERS, 2010, 25 (07) : S431 - S431
  • [14] Effects of levodopa on motor sequence learning in Parkinson's disease
    Feigin, A
    Ghilardi, MF
    Carbon, M
    Edwards, C
    Fukuda, M
    Dhawan, V
    Margouleff, C
    Ghez, C
    Eidelberg, D
    NEUROLOGY, 2003, 60 (11) : 1744 - 1749
  • [15] The effects of paroxetine on clinical response to levodopa in Parkinson's disease
    Chung, KA
    Nutt, JG
    NEUROLOGY, 2004, 62 (07) : A331 - A331
  • [16] Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson's Disease
    Mueller, Karsten
    Jech, Robert
    Ballarini, Tommaso
    Holiga, Stefan
    Ruzicka, Filip
    Piecha, Fabian A.
    Moeller, Harald E.
    Vymazal, Josef
    Ruzicka, Evzen
    Schroeter, Matthias L.
    CEREBELLUM, 2019, 18 (02): : 212 - 224
  • [17] Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
    Karsten Mueller
    Robert Jech
    Tommaso Ballarini
    Štefan Holiga
    Filip Růžička
    Fabian A. Piecha
    Harald E. Möller
    Josef Vymazal
    Evžen Růžička
    Matthias L. Schroeter
    The Cerebellum, 2019, 18 : 212 - 224
  • [18] Levodopa Effects on Visuospatial Working Memory in Parkinson's Disease
    Bayram, E.
    Litvan, I.
    Wright, B.
    Grembowski, C.
    Harrington, D.
    MOVEMENT DISORDERS, 2019, 34 : S679 - S681
  • [19] Developmental stuttering and Parkinson's disease: the effects of levodopa treatment
    Anderson, JM
    Hughes, JD
    Rothi, LJG
    Crucian, GP
    Heilman, KM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (06): : 776 - 778
  • [20] Effects of Parkinson's disease and levodopa on functional limits of stability
    Mancini, Martina
    Rocchi, Laura
    Horak, Fay B.
    Chiari, Lorenzo
    CLINICAL BIOMECHANICS, 2008, 23 (04) : 450 - 458